Metastatic Mature Teratoma and Growing Teratoma Syndrome in Patients with Testicular Non-Seminomatous Germ Cell Tumors

Korean J Radiol. 2021 Oct;22(10):1650-1657. doi: 10.3348/kjr.2020.1391. Epub 2021 Jul 26.

Abstract

Metastatic mature teratoma is a common radiologic and histopathologic finding after chemotherapy for metastatic non-seminomatous germ cell tumors. The leading theory for these residual tumors is the selective chemotherapy resistance of teratomas versus the high chemotherapy sensitivity of the embryonal components. Growing teratoma syndrome is a relatively rare phenomenon defined as an enlarging residual mass histologically proven to be a mature teratoma in the setting of normal serum tumor markers. Metastatic mature teratomas should be resected because of their malignant potential and occasional progression to growing teratoma syndrome with the invasion of the surrounding structures. CT is the preferred imaging modality for post-chemotherapy surveillance and should cover all sites of potential metastatic disease. This article reviews the clinical, pathologic, and multimodality imaging features of metastatic mature teratomas in patients with primary testicular non-seminomatous germ cell tumors.

Keywords: Growing teratoma syndrome; Metastatic mature teratoma; Non-seminomatous germ cell tumor; Surveillance imaging; Testicular cancer.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Humans
  • Male
  • Neoplasm, Residual
  • Neoplasms, Germ Cell and Embryonal* / diagnostic imaging
  • Neoplasms, Germ Cell and Embryonal* / drug therapy
  • Syndrome
  • Teratoma* / diagnostic imaging
  • Testicular Neoplasms* / diagnostic imaging
  • Testicular Neoplasms* / drug therapy